Netherlands
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 308.21 M
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
|
2 |
USD -24.00 K
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
3 |
USD -99.32 K
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
4 |
USD -17.64 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
5 |
USD -27.02 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
The Vaccines company in Netherlands with the highest Net Cash Used For Investing Activities is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 308.21 M.
The Vaccines company in Netherlands with the lowest Net Cash Used For Investing Activities is Merus N.V. (NasdaqGM: MRUS) at USD -27.02 M.
The top 10 Vaccines companies in Netherlands by Net Cash Used For Investing Activities are argenx SE, NewAmsterdam Pharma Company N.V., Pharvaris N.V., LAVA Therapeutics N.V. and Merus N.V..
The bottom 10 Vaccines companies in Netherlands by Net Cash Used For Investing Activities are Merus N.V., LAVA Therapeutics N.V., Pharvaris N.V., NewAmsterdam Pharma Company N.V. and argenx SE.